<DOC>
	<DOCNO>NCT00123669</DOCNO>
	<brief_summary>The purpose study test effect primary progesterone overall disease free survival woman operable breast cancer . The study address two issue relate breast cancer surgery : - Circulating progesterone time surgery might counteract detrimental effect estrogen survival woman operable breast cancer . - Events time surgery may impact natural history breast cancer</brief_summary>
	<brief_title>Primary Progesterone Therapy Operable Breast Cancer</brief_title>
	<detailed_description>This protocol address issue pre-operative hormone manipulation woman operable breast cancer . The study design careful review literature assess effect unopposed oestrogen time surgery collect evidence event time surgery may impact long-term survival breast cancer patient . The meta-analysis 37 study time surgery menstrual cycle show 15 % + 3 improvement survival woman undergone surgery luteal phase menstrual cycle . Three 37 study progesterone level estimate time surgery show 52 % + 26 improvement survival circulate progesterone &gt; 1.5 ng/ml . The study aim produce luteal milieu inject Hydroxy- progesterone 500 mg IM time surgery . The timing administration progesterone neo-adjuvant setting decide collate data large data-bases randomise trial screen suggest event time surgery may alter behavior micro-metastases .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>17-alpha-hydroxy-progesterone caproate</mesh_term>
	<mesh_term>11-hydroxyprogesterone</mesh_term>
	<criteria>Unilateral operable palpable breast cancer Previous history excision biopsy primary tumour History epithelial/mesenchymal malignant tumour except basal cell carcinoma/squamous cell carcinoma ( BCC/SCC ) skin</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Cancer Breast</keyword>
	<keyword>Neoplasm</keyword>
</DOC>